3644 results for «2818»
3644 results
AI adoption in the cathlab of tomorrow - Risk prediction applications
20 May 2026 – From EuroPCR 2026
This session delves into the adoption of artificial intelligence in the cath lab, focusing on clinically useful risk prediction models for coronary and structural interventions. It covers advanced AI-guided intravascular imaging, machine learning applications for adverse event prediction, and critical evaluation of model validation and clinical...
Intracoronary imaging guidance in challenging PCI scenarios
20 May 2026 – From EuroPCR 2026
This session highlights the critical role of intracoronary imaging, particularly IVUS, in guiding complex percutaneous coronary interventions. It presents techniques such as IVUS-guided puncture of neo-ostia, stent implantation for ostial lesions, and innovative procedural methods like the Heart POTTER technique, underscoring the importance of precise imaging...
Complex endovascular and pulmonary interventions
20 May 2026 – From EuroPCR 2026
Explore advances in complex endovascular and pulmonary interventions, including the transformation of interventional labs into intelligent learning ecosystems, innovative approaches to peripheral and coronary CTOs, and novel therapies such as extravascular renal denervation and fixation catheters for acute pulmonary embolism.
Beyond first implant: valve-in-valve, redo and leaflet modification
20 May 2026 – From EuroPCR 2026
This session explores advanced transcatheter aortic valve therapies beyond the first implant, focusing on valve-in-valve, redo procedures, and leaflet modification techniques. Topics include bioprosthetic valve fracture, long-term outcomes from the DURA-ViV registry, simplified workflows for leaflet modification in redo-TAVI, and intravascular ultrasound evaluation of valve expansion...
First-in-human studies in cardiovascular devices: from first 10 patients to global innovation — How efficient early studies advance emerging technologies
20 May 2026 – From EuroPCR 2026
Understand the pivotal role of first-in-human studies in advancing cardiovascular device innovation through operational insights from early patient experiences. This session reviews cutting-edge technologies including percutaneous left ventricular assist devices, transcatheter leaflet augmentation, physiology-guided PCI, synchronized diaphragmatic stimulation, pulmonary artery denervation, and perspectives on translating early...
TAVI complications: the nurses and allied professionals' perspective
20 May 2026 – From EuroPCR 2026
This session highlights the critical role nurses and allied professionals (NAPs) play during TAVI complications. Through detailed clinical cases, it emphasizes their contributions in managing adverse events and explores the significance of structured debriefing to enhance team performance and patient outcomes.
Coronary innovations and artificial intelligence: new devices, smarter tools, better outcomes
20 May 2026 – From EuroPCR 2026
This session provides a practical update on emerging coronary innovations and AI technologies, including next-generation calcium modification devices, bioresorbable scaffolds, sirolimus drug-coated balloons, and AI-driven coronary physiology and imaging tools. It offers a roadmap for integrating these advancements into clinical practice, addressing technology selection, reimbursement, training,...
The dark side of calcium: complications, crashes and comebacks
20 May 2026 – From EuroPCR 2026
Focused on the formidable challenges posed by coronary calcium, this session presents three compelling cases illustrating complications, procedural crashes, and successful recoveries. Participants learn detailed approaches to treating PCI complications related to calcified lesions and develop a skillset aimed at prevention and effective management of these...
Tricuspid interventions: find the best candidate
20 May 2026 – From EuroPCR 2026
This session reviews the phenotypes of tricuspid regurgitation and their diagnostic pathways, emphasizing standardized and pragmatic diagnostic steps. It also addresses criteria for identifying optimal timing and candidates for tricuspid valve interventions.
New TAVI platforms - Novel devices, early data
20 May 2026 – From EuroPCR 2026
Explore the latest developments in TAVI technology, featuring novel valve platforms and early clinical data. The session covers outcomes from new self-expandable and balloon-expandable valves, innovative single-operator techniques, redo TAVI approaches, and advances in CT sizing powered by deep learning.
TAVI procedural complications - Part 5: vascular complications, coronary issues and more
20 May 2026 – From EuroPCR 2026
This session addresses procedural complications during TAVI, focusing on vascular complications, coronary issues, and rare device-related events. It includes case analyses of aortic dissection, valve infolding, stent dislodgement, and management strategies for complex anatomical challenges.
Tackling calcified lesions with IVUS guidance and optimisation
20 May 2026 – From EuroPCR 2026
This session delves into the critical role of Intravascular Ultrasound (IVUS) in characterizing and managing calcified coronary lesions. Attendees can explore an imaging-guided approach to calcium treatment, including case presentations that demonstrate stent selection and procedural optimization. Emphasis is placed on applying imaging-based optimization metrics to...
Complications during left main PCI: how to manage and how to avoid
20 May 2026 – From EuroPCR 2026
This session addresses the identification, prevention, and management of complications arising during left main percutaneous coronary intervention (PCI). Through detailed case presentations and analyses, it highlights anatomical and procedural risk factors, strategies to anticipate and recognize complications such as stent deformation and coronary perforation, and effective...
Safe management of assisted PCI : what can go wrong
20 May 2026 – From EuroPCR 2026
Explore the complexities and potential complications associated with assisted PCI in this session. Topics include challenges such as microaxial pump kinks, technical aspects of IMPELLA device deployment, and the management of high-risk PCI cases including patients with prior TAVI, highlighting strategies to mitigate risks during protected...
TAVI: head-to-head trials
20 May 2026 – From EuroPCR 2026
This session presents head-to-head comparisons of TAVI devices from recent randomized trials and registries. Highlights include three-year outcomes from the SMART trial, two-year data from the LANDMARK trial on contemporary valves, comparisons of intra- and supra-annular self-expanding valves, evaluations in large annuli, the ALLEGRA trial focusing...
Assessment of vasomotor coronary disorders in the cathlab
20 May 2026 – From EuroPCR 2026
This session focuses on the invasive assessment of vasomotor coronary disorders within the catheterization laboratory. It reviews clinical profiles, endothelial function evaluation using acetylcholine and advanced hemodynamic methods, coronary volume analysis, and refined classification of coronary spasm, enhancing diagnostic accuracy in patients with suspected ischemia and...
Lost, crushed, fractured: stent complications in real life
20 May 2026 – From EuroPCR 2026
This session addresses real-world challenges of stent complications including loss, crushing, and fracture during PCI. Through case-based discussions, it explores complex scenarios such as stent dislodgement, embolisation, and management strategies when initial plans evolve into complicated realities.
Management of calcified lesions in challenging scenarios
20 May 2026 – From EuroPCR 2026
This session presents complex cases involving calcified coronary lesions in challenging clinical scenarios including STEMI, bifurcation lesions, tortuosity, and concurrent TAVI procedures. It demonstrates integrative strategies such as rota-lithotripsy and addresses decision-making processes in managing calcification beyond the coronaries to optimize patient outcomes.
All you need to know about interventional therapies for pulmonary embolism
20 May 2026 – From EuroPCR 2026
Focused on interventional therapies for pulmonary embolism, this session guides on establishing and sustaining Pulmonary Embolism Response Teams (PERT), refining patient selection for intervention, choosing appropriate technologies, and identifying intraprocedural markers indicating successful treatment outcomes.
TAVI: new approach
20 May 2026 – From EuroPCR 2026
This session introduces new frontiers in transcatheter aortic valve implantation (TAVI), including artificial intelligence-enabled systems and minimalist, radiation-free approaches guided by echocardiography. It covers complex procedural techniques such as axillary access under TEE guidance, precision snaring, and managing challenging anatomies, emphasizing advancements in safety and efficacy...
